Surescripts Acquires ActiveRADAR to Offer Therapeutic Alternatives for Prescriptions

Surescripts®, the nation's leading health information network, acquired ActiveRADAR, a clinical intelligence company that identifies therapeutic alternatives for prescriptions.

“We are always looking for ways to broaden our impact on patients and the people who care for them,” explained Frank Harvey, Chief Executive Officer of Surescripts. “Our acquisition of ActiveRADAR underscores our commitment to optimizing our network solutions with even more comprehensive clinical and cost data available at the point of prescribing. Together, we can make it simpler and faster to get patients started on the best medication for them.”

ActiveRADAR (formerly known as RxTE Health) offers evidence-based, formulary-specific and medically accepted use-specific therapeutic alternatives, along with corresponding dosage strengths, quantities, and plan-specific patient and health plan costs. ActiveRADAR’s Clinical Catalogue covers more than 165 therapeutic categories, including more than 30 specialty drug categories and more than 33,000 drug pairs, as well as both clinical and economic value on medication alternatives, and has been shown to reduce costs for employers and employees by 15 to 20%.

“We are very pleased to have reached this agreement which will allow ActiveRADAR to have a direct impact on improving medication adherence as well as patient and provider engagement,” said Dave Teckman, former Chief Executive Officer of ActiveRADAR. “Our analytical processes target and prioritize savings opportunities to minimize member disruption and maximize savings, which ultimately improves the patient experience and takes waste and costs out of the system.”

“Providing faster access to insights and optimizing the value delivered by our data are two of our biggest priorities, so we’re thrilled to have the ActiveRADAR team joining Surescripts,” said Dr. Lynne Nowak, Chief Data & Analytics Officer of Surescripts. “With access to their extensive catalog of therapeutic alternatives data, we can reduce drug spend and help provide more alternatives when deploying prescription pricing information to providers.”

Surescripts connects more than 2 million healthcare professionals and providers with plan-level formulary details to support more-informed conversations for a better patient experience. In 2022, Surescripts processed 2.34 billion electronic prescriptions filled by pharmacies nationwide, and as of October 2023, more than 777,000 prescribers in the United States use Surescripts Real-Time Prescription Benefit, saving patients an average of $61 on traditional prescriptions and $428 on specialty medications.

###

About Surescripts

Our purpose is to serve the nation through simpler, trusted health intelligence sharing, in order to increase patient safety, lower costs and ensure quality care. At Surescripts, we align healthcare organizations across the nation and convene the Surescripts Network Alliance® to give healthcare professionals the trusted insights they need to serve patients. Together, we’re making interoperability an everyday reality, making it simpler to choose medications patients can afford and adhere to, and getting specialty medications to patients more efficiently. Visit us at surescripts.com and follow us at twitter.com/surescripts.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231106083978/en/